ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

33,915Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 551

$1.76M Total Retail Price of All Prescriptions

Rank: 1 out of 551

1,273 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
3% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 1,273 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

2% of this provider’s 1,273 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Risky Drugs to Seniors

3% of this provider’s 21,676 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $35 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
SIMVASTATIN 1,517 960 1 1
AMLODIPINE BESYLATE 1,080 759 2 4
GABAPENTIN 1,065 666 3 3
OMEPRAZOLE 983 688 4 7
LOSARTAN POTASSIUM 973 662 5 6
RANITIDINE HCL 954 566 6 8
ENALAPRIL MALEATE 896 556 7 5
METFORMIN HCL 824 538 8 2
METOPROLOL TARTRATE 698 487 9 17
TRAMADOL HCL-ACETAMINOPHEN 630 409 10 18
DIOVAN 558 406 11 57
FUROSEMIDE 515 322 12 13
NABUMETONE 511 257 13 37
ZOLPIDEM TARTRATE 473 316 14 27
SYNTHROID 469 278 15 11
LEVOTHYROXINE SODIUM 432 342 16 9
ETODOLAC 413 254 17 95
DOXAZOSIN MESYLATE 406 268 18 25
LANTUS 399 283 19 28
METOPROLOL SUCCINATE 398 244 20 23
GLIMEPIRIDE 373 286 21 16
LOSARTAN-HYDROCHLOROTHIAZIDE 372 235 22 10
ALENDRONATE SODIUM 368 271 23 19
ATENOLOL 358 243 24 12
HUMULIN 70-30 347 203 10 25 35
CARVEDILOL 335 254 26 22
ISOSORBIDE MONONITRATE ER 329 281 27 21
PLAVIX 322 261 28 33
GLYBURIDE-METFORMIN HCL 321 243 R 29 48
GLIPIZIDE 319 221 30 20
LISINOPRIL 311 209 31 14
EVISTA 300 245 32 52
DIOVAN HCT 286 155 33 71
PANTOPRAZOLE SODIUM 282 142 34 36
TAMSULOSIN HCL 280 229 35 38
CLOPIDOGREL 276 232 36 30
SINGULAIR 276 149 36 58
DIGOXIN 254 227 38 44
LANSOPRAZOLE 242 156 39 72
SULINDAC 242 188 39 78
HUMALOG 229 112 41 101
FLUTICASONE PROPIONATE 223 106 42 66
AMLODIPINE BESYLATE-BENAZEPRIL 223 167 42 42
OXYCODONE-ACETAMINOPHEN 211 46 S2 44 102
MECLIZINE HCL 205 159 45 56
PAROXETINE HCL 199 133 46 77
PREDNISONE 189 94 47 65
FEXOFENADINE HCL 185 111 48 143
DIPYRIDAMOLE 182 136 R 49 76
LYRICA 182 106 49 86
ZETIA 181 97 51 69
SURE COMFORT 177 107 52 74
WARFARIN SODIUM 169 119 53 46
ATORVASTATIN CALCIUM 168 118 54 29
INSULIN SYRINGE 167 86 55 41
SERTRALINE HCL 162 109 56 43
JANUVIA 156 125 57 87
AZITHROMYCIN 155 86 58 55
HUMULIN N 150 115 59 47
LEVOXYL 150 114 59 40
CRESTOR 150 114 59 62
ADVAIR DISKUS 148 54 62 97
DONEPEZIL HCL 147 143 63 50
CLOTRIMAZOLE-BETAMETHASONE 145 94 64 49
PROAIR HFA 141 46 65 92
FLUOXETINE HCL 140 70 66 93
AVELOX 139 88 67 148
VERAPAMIL ER 126 97 68 39
GEMFIBROZIL 125 66 69 61
CYMBALTA 120 44 70 105
CIPROFLOXACIN HCL 116 76 71 54
PRAVASTATIN SODIUM 110 67 72 24
SULFAMETHOXAZOLE-TRIMETHOPRIM 109 57 73 119
LEVOFLOXACIN 107 69 74 117
METOLAZONE 103 66 75 142
SPIRIVA 101 31 76 133
SPIRONOLACTONE 101 93 76 79
CELEBREX 100 42 78 218
VYTORIN 100 62 78 132
HYDROCHLOROTHIAZIDE 100 81 78 15
PRAMIPEXOLE DIHYDROCHLORIDE 98 57 81 196
TRAMADOL HCL 97 60 82 32
HUMULIN R 96 53 83 161
AMITRIPTYLINE HCL 96 56 R 83 96
NIFEDIPINE ER 93 72 85 75
ISOSORBIDE DINITRATE 86 61 86 100
CYCLOBENZAPRINE HCL 86 24 R 86 184
NEXIUM 86 41 86 300
AVAPRO 85 66 89 83
IRBESARTAN 84 62 90 51
LEVEMIR 83 39 91 210
BETAMETHASONE DIPROPIONATE 83 39 91 127
KETOCONAZOLE 83 29 91 134
MONTELUKAST SODIUM 78 39 94 156
ASPIRIN EC 77 70 95 26
DIVALPROEX SODIUM 73 24 96 206
CILOSTAZOL 73 69 96 64
RAMIPRIL 72 38 98 53
QUETIAPINE FUMARATE 69 38 99 171
NAMENDA 68 65 100 94
GLYBURIDE 67 63 R 101 70
ALCOHOL SWABS 66 37 102 256
FAMOTIDINE 66 42 102 31
DICYCLOMINE HCL 66 30 102 201
TRAZODONE HCL 66 27 102 167
PHENYTOIN SODIUM EXTENDED 63 49 106 163
METOCLOPRAMIDE HCL 61 31 107 107
GLYCOPYRROLATE 59 33 108 346
METAXALONE 59 23 R 108 346
CLONIDINE HCL 58 26 110 60
SYMBICORT 58 27 110 292
AMOX TR-POTASSIUM CLAVULANATE 57 31 112 113
SULFASALAZINE 55 40 113 360
HALOPERIDOL 54 34 114 257
CARISOPRODOL 53 24 R 115 364
PENTOXIFYLLINE 53 40 115 73
LEVOCETIRIZINE DIHYDROCHLORIDE 53 24 115 195
DOXEPIN HCL 52 24 118 203
ONGLYZA 51 26 119 145
LEVETIRACETAM 50 31 120 182
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 4, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.